Miskolc, Hungary

Arpad Kovacs

This inventor holds 1 USPTO granted patent. Top assignee: Eliza nor Biopharmaceuticals, Inc.. Active years: 2001.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Arpad Kovacs: Innovator in Therapeutic Derivatives

Introduction

Arpad Kovacs is a notable inventor based in Miskolc, Hungary. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of therapeutic derivatives of diphosphonates. His work focuses on creating compounds that have utility in treating various disease states.

Latest Patents

Kovacs holds a patent for "Therapeutic derivatives of diphosphonates." This invention involves compounds that are prepared by reacting a 2,2-bis-(disubstituted-phosphoryl)-ethylsulfanyl-acetic acid compound with a pharmaceutically active chemical entity. These compounds are effective in treating underlying disease states or can be combined with non-pharmaceutical entities such as pesticides, insecticides, fungicides, or poisons for vermin.

Career Highlights

Arpad Kovacs is associated with Eliza Nor Biopharmaceuticals, Inc., where he continues to innovate in the biopharmaceutical sector. His work has led to advancements in therapeutic applications, showcasing his commitment to improving health outcomes through innovative solutions.

Collaborations

Kovacs has collaborated with notable colleagues, including Ferenc J. Sztaricskai and Pal Herczegh. These partnerships have contributed to the development of his patented technologies and have enhanced the research capabilities within his field.

Conclusion

Arpad Kovacs is a distinguished inventor whose work in therapeutic derivatives has the potential to impact the biopharmaceutical industry significantly. His innovative approach and collaborations highlight the importance of teamwork in advancing medical science.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…